Infinity Pharmaceuticals, Inc.- Halper Sadeh

Infinity Pharmaceuticals, Inc.

If you purchased Infinity Pharmaceuticals, Inc. securities and would like to join the action, please click "Join This Action" below.

We would handle the action on a contingent fee basis, whereby you would not be responsible for payment of our legal fees or expenses in the action.

INFI STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE MERGER OF INFINITY PHARMACEUTICALS, INC. IS FAIR TO SHAREHOLDERS

February 23, 2023.

New York, New York—Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and MEI Pharma, Inc. is fair to Infinity shareholders.

Per the merger agreement, pre-merger MEI shareholders are expected to own approximately 58.0% and pre-merger Infinity shareholders are expected to own approximately 42.0% of the outstanding equity of the combined company immediately following the merger.

The investigation concerns whether Infinity and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Infinity shareholders; and (2) disclose all material information necessary for Infinity shareholders to adequately assess and value the merger consideration. On behalf of Infinity shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Certification

Full Name or Entity*

If Representing an Entity, Position at Entity

Street Address*

Address Line 2

City*

State*

Zip Code*

Country*

Phone*

E-Mail Address*

Number of Shares Currently Owned*

Date Shares Were Acquired*

Average Cost Per Share*

I currently hold, and will continue to hold, at least one share of Infinity Pharmaceuticals, Inc. while the matter, if any, is pending.*

By signing and clicking the “submit” button below, I hereby execute the Retainer Agreement and agree to retain Halper Sadeh LLC in the Infinity Pharmaceuticals, Inc. shareholder matter on a contingent fee basis pursuant to the terms set forth in the provided Retainer Agreement, which is incorporated by reference herein. Pursuant to the Retainer Agreement, which is effective upon execution by Halper Sadeh LLC, Halper Sadeh LLC will advance all costs and expenses pursuant to the terms set forth in the Retainer Agreement.*

I declare under penalty of perjury, under the laws of the United States of America, that the information entered is accurate.*

Draw Your Signature Below*

Signed pursuant to California Civil Code Section 1633.1, et seq., and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: June 04, 2023

Retainer Agreement